JP2009509964A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009509964A5 JP2009509964A5 JP2008532459A JP2008532459A JP2009509964A5 JP 2009509964 A5 JP2009509964 A5 JP 2009509964A5 JP 2008532459 A JP2008532459 A JP 2008532459A JP 2008532459 A JP2008532459 A JP 2008532459A JP 2009509964 A5 JP2009509964 A5 JP 2009509964A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- carbon atoms
- azabicyclo
- oct
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 551
- 125000004432 carbon atom Chemical group C* 0.000 claims 478
- -1 carboxymethyl -O Chemical class 0.000 claims 176
- 150000001875 compounds Chemical class 0.000 claims 108
- 229910052799 carbon Inorganic materials 0.000 claims 97
- 125000000753 cycloalkyl group Chemical group 0.000 claims 82
- 125000003342 alkenyl group Chemical group 0.000 claims 80
- 125000000304 alkynyl group Chemical group 0.000 claims 80
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 66
- 125000003545 alkoxy group Chemical group 0.000 claims 62
- 150000003839 salts Chemical class 0.000 claims 57
- 125000004663 dialkyl amino group Chemical group 0.000 claims 56
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 48
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 46
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 45
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 45
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 40
- 125000005113 hydroxyalkoxy group Chemical group 0.000 claims 38
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 33
- 239000012453 solvate Substances 0.000 claims 33
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 32
- 125000003118 aryl group Chemical group 0.000 claims 26
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 claims 26
- 229910052794 bromium Inorganic materials 0.000 claims 25
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 25
- 229910052801 chlorine Inorganic materials 0.000 claims 25
- 229910052731 fluorine Inorganic materials 0.000 claims 25
- 229910052739 hydrogen Inorganic materials 0.000 claims 25
- 229910052740 iodine Inorganic materials 0.000 claims 25
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 25
- 229910052757 nitrogen Inorganic materials 0.000 claims 24
- 239000002585 base Substances 0.000 claims 22
- 229920001577 copolymer Chemical group 0.000 claims 22
- 239000000203 mixture Substances 0.000 claims 22
- 150000001349 alkyl fluorides Chemical class 0.000 claims 21
- 125000000623 heterocyclic group Chemical group 0.000 claims 21
- TYUVKZGQQUXSOU-UHFFFAOYSA-N [C].OF Chemical compound [C].OF TYUVKZGQQUXSOU-UHFFFAOYSA-N 0.000 claims 20
- 229910052760 oxygen Inorganic materials 0.000 claims 20
- 125000006413 ring segment Chemical group 0.000 claims 20
- 229920006395 saturated elastomer Polymers 0.000 claims 20
- YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 claims 19
- 125000004414 alkyl thio group Chemical group 0.000 claims 18
- 150000001204 N-oxides Chemical class 0.000 claims 17
- 229910052736 halogen Inorganic materials 0.000 claims 16
- 150000002367 halogens Chemical class 0.000 claims 16
- 229910052717 sulfur Inorganic materials 0.000 claims 15
- 150000001350 alkyl halides Chemical class 0.000 claims 14
- 125000004043 oxo group Chemical group O=* 0.000 claims 13
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 12
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 10
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 125000004423 acyloxy group Chemical group 0.000 claims 8
- 125000003282 alkyl amino group Chemical group 0.000 claims 8
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 8
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 239000012458 free base Substances 0.000 claims 8
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 6
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 claims 5
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 claims 5
- LLSRLLPHUVVLQJ-UHFFFAOYSA-N 1-cycloheptyldiazepane Chemical group C1CCCCCC1N1NCCCCC1 LLSRLLPHUVVLQJ-UHFFFAOYSA-N 0.000 claims 5
- YNUPAYMXLKKJQU-UHFFFAOYSA-N 2-amino-2-hydroxy-2-nitroacetonitrile Chemical compound N#CC(O)(N)[N+]([O-])=O YNUPAYMXLKKJQU-UHFFFAOYSA-N 0.000 claims 5
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 5
- 125000003302 alkenyloxy group Chemical group 0.000 claims 5
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims 5
- 125000002947 alkylene group Chemical group 0.000 claims 5
- 125000005110 aryl thio group Chemical group 0.000 claims 5
- 125000004104 aryloxy group Chemical group 0.000 claims 5
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 claims 5
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000005338 substituted cycloalkoxy group Chemical group 0.000 claims 5
- FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 claims 4
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 4
- GGTBELZDHKHESR-UHFFFAOYSA-N 2-cycloheptyloxazepane Chemical group C1CCCCCC1N1OCCCCC1 GGTBELZDHKHESR-UHFFFAOYSA-N 0.000 claims 4
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 4
- CHHKUKIZVHLZHF-WMZOPIPTSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 CHHKUKIZVHLZHF-WMZOPIPTSA-N 0.000 claims 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 3
- 150000003857 carboxamides Chemical class 0.000 claims 3
- LJEXBQWZLZFSSN-HNNXBMFYSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-1-ethyl-6-methoxyindazole-3-carboxamide Chemical compound C12=CC=C(OC)C=C2N(CC)N=C1C(=O)N[C@@H]1C(CC2)CCN2C1 LJEXBQWZLZFSSN-HNNXBMFYSA-N 0.000 claims 3
- KPKFCXSWRVNEBQ-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-(cyclopropylmethyl)-6-(1,3-oxazol-2-yl)indazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=C(C=C11)C=2OC=CN=2)=NN1CC1CC1 KPKFCXSWRVNEBQ-GOSISDBHSA-N 0.000 claims 3
- VQDFGMVDXFKJGX-CYBMUJFWSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-(difluoromethyl)-6-methoxyindazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@@H]1NC(=O)C1=NN(C(F)F)C2=CC(OC)=CC=C21 VQDFGMVDXFKJGX-CYBMUJFWSA-N 0.000 claims 3
- SMJVOFILIBVERT-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-cyclopropyl-6-(propylcarbamoylamino)indazole-3-carboxamide Chemical compound C12=CC(NC(=O)NCCC)=CC=C2C(C(=O)N[C@H]2C3CCN(CC3)C2)=NN1C1CC1 SMJVOFILIBVERT-GOSISDBHSA-N 0.000 claims 3
- LJEXBQWZLZFSSN-OAHLLOKOSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-ethyl-6-methoxyindazole-3-carboxamide Chemical compound C12=CC=C(OC)C=C2N(CC)N=C1C(=O)N[C@H]1C(CC2)CCN2C1 LJEXBQWZLZFSSN-OAHLLOKOSA-N 0.000 claims 3
- AOPGWWFRFLXWRH-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-ethyl-n-methyl-6-(1,3-oxazol-2-yl)indazole-3-carboxamide Chemical compound C1=C2N(CC)N=C(C(=O)N(C)[C@H]3C4CCN(CC4)C3)C2=CC=C1C1=NC=CO1 AOPGWWFRFLXWRH-GOSISDBHSA-N 0.000 claims 3
- XHLPSFUPKCQDKE-QGZVFWFLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-propyl-6-(1,3-thiazol-2-yl)indazole-3-carboxamide Chemical compound C1=C2N(CCC)N=C(C(=O)N[C@H]3C4CCN(CC4)C3)C2=CC=C1C1=NC=CS1 XHLPSFUPKCQDKE-QGZVFWFLSA-N 0.000 claims 3
- NBLLSKMFNOYWGA-CQSZACIVSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-5-(difluoromethoxy)-n-methyl-1h-indazole-3-carboxamide Chemical compound C1=C(OC(F)F)C=C2C(C(=O)N([C@H]3C4CCN(CC4)C3)C)=NNC2=C1 NBLLSKMFNOYWGA-CQSZACIVSA-N 0.000 claims 3
- CDIIRPQKBBSHHC-OAHLLOKOSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-5-methoxy-n-methyl-1h-indazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@@H]1N(C)C(=O)C1=NNC2=CC=C(OC)C=C21 CDIIRPQKBBSHHC-OAHLLOKOSA-N 0.000 claims 3
- RDSODELYJDFMBF-LJQANCHMSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-n-methyl-5-(oxan-4-yl)-1h-indazole-3-carboxamide Chemical compound CN([C@H]1C2CCN(CC2)C1)C(=O)C(C1=C2)=NNC1=CC=C2C1CCOCC1 RDSODELYJDFMBF-LJQANCHMSA-N 0.000 claims 3
- VHMKMIXTXOLLSO-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-n-methyl-6-(1,3-oxazol-2-yl)-1h-indazole-3-carboxamide Chemical compound CN([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NNC1=CC=2C1=NC=CO1 VHMKMIXTXOLLSO-MRXNPFEDSA-N 0.000 claims 3
- YMWLIMACGUHANC-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-n-methyl-6-(1,3-thiazol-2-yl)-1h-indazole-3-carboxamide Chemical compound CN([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NNC1=CC=2C1=NC=CS1 YMWLIMACGUHANC-MRXNPFEDSA-N 0.000 claims 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 3
- 125000006308 propyl amino group Chemical group 0.000 claims 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims 3
- OEJKUAYPQOVDOO-NNBQYGFHSA-N 6-(3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl)-n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1CN2CCCC2CN1C1=CC=C2C(C(N[C@@H]3C4CCN(CC4)C3)=O)=NSC2=C1 OEJKUAYPQOVDOO-NNBQYGFHSA-N 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 2
- 125000005047 dihydroimidazolyl group Chemical group N1(CNC=C1)* 0.000 claims 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- YVMOPDSEFSCIBW-SFHVURJKSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-5-(oxan-4-yloxy)-1h-indazole-3-carboxamide Chemical compound N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=C2)=NNC1=CC=C2OC1CCOCC1 YVMOPDSEFSCIBW-SFHVURJKSA-N 0.000 claims 2
- PBHKPYHGXWPPBB-KRWDZBQOSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(1,4-diazepan-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N1CCCNCC1 PBHKPYHGXWPPBB-KRWDZBQOSA-N 0.000 claims 2
- OPCOSSJANZPAQC-OYKVQYDMSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(1-azabicyclo[2.2.2]octan-3-yloxy)-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2C1OC1=CC=C2C(C(N[C@@H]3C4CCN(CC4)C3)=O)=NSC2=C1 OPCOSSJANZPAQC-OYKVQYDMSA-N 0.000 claims 2
- GPWNPAULGBLLEA-TVPLGVNVSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(5-methyl-2,5-diazabicyclo[2.2.2]octan-2-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@H]1NC(=O)C1=NSC2=CC(N3CC4CCC3CN4C)=CC=C21 GPWNPAULGBLLEA-TVPLGVNVSA-N 0.000 claims 2
- YIPLPZONCABMSW-QRTARXTBSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(1s,4s)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@H]1NC(=O)C1=NSC2=CC(N3C[C@]4(NC[C@]3([H])C4)[H])=CC=C21 YIPLPZONCABMSW-QRTARXTBSA-N 0.000 claims 2
- MQHHLXJJSOOTSK-ZBFHGGJFSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@H](O)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 MQHHLXJJSOOTSK-ZBFHGGJFSA-N 0.000 claims 2
- JRLOWLLNQWPBTN-IBYPIGCZSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-(methoxymethyl)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1C(COC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 JRLOWLLNQWPBTN-IBYPIGCZSA-N 0.000 claims 2
- OFFFQICGZLVGEA-JRZJBTRGSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-(methylamino)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1C(NC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 OFFFQICGZLVGEA-JRZJBTRGSA-N 0.000 claims 2
- KWZVHFOFVCRKOY-ZDUSSCGKSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-methoxy-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@H]1NC(=O)C1=NSC2=CC(OC)=CC=C21 KWZVHFOFVCRKOY-ZDUSSCGKSA-N 0.000 claims 2
- PIDKUZOOEPTSPI-RDJZCZTQSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=CC2=C1SN=C2C(=O)N[C@@H]1C(CC2)CCN2C1 PIDKUZOOEPTSPI-RDJZCZTQSA-N 0.000 claims 2
- SNBVUKVTZTVDTO-WUJWULDRSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-fluoro-6-(3-methoxypyrrolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1C(OC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1F SNBVUKVTZTVDTO-WUJWULDRSA-N 0.000 claims 2
- ZGGYIVUEFFUZRX-GFCCVEGCSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1h-pyrazolo[3,4-c]pyridine-3-carboxamide Chemical compound N1=CC=C2C(C(N[C@H]3C4CCN(CC4)C3)=O)=NNC2=C1 ZGGYIVUEFFUZRX-GFCCVEGCSA-N 0.000 claims 2
- FEDPYWYAMNIXBE-UTONKHPSSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1h-pyrazolo[3,4-c]pyridine-3-carboxamide;formic acid Chemical compound OC=O.N1=CC=C2C(C(N[C@H]3C4CCN(CC4)C3)=O)=NNC2=C1 FEDPYWYAMNIXBE-UTONKHPSSA-N 0.000 claims 2
- PPNSPIJCCHPEIW-NVXWUHKLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-5-[(3r)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@H](OC)CCN1C1=CC=C(SN=C2C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 PPNSPIJCCHPEIW-NVXWUHKLSA-N 0.000 claims 2
- MRWSLRJLSYNXEP-QGZVFWFLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(1,3-oxazol-2-yl)-1-propylindazole-3-carboxamide Chemical compound C1=C2N(CCC)N=C(C(=O)N[C@H]3C4CCN(CC4)C3)C2=CC=C1C1=NC=CO1 MRWSLRJLSYNXEP-QGZVFWFLSA-N 0.000 claims 2
- OPCOSSJANZPAQC-MRTLOADZSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(1-azabicyclo[2.2.2]octan-3-yloxy)-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2C1OC1=CC=C2C(C(N[C@H]3C4CCN(CC4)C3)=O)=NSC2=C1 OPCOSSJANZPAQC-MRTLOADZSA-N 0.000 claims 2
- UFVCXVYNCMTGHK-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(1-methyl-4,5-dihydroimidazol-2-yl)-1h-indazole-3-carboxamide Chemical compound CN1CCN=C1C1=CC=C(C(=NN2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 UFVCXVYNCMTGHK-MRXNPFEDSA-N 0.000 claims 2
- GRUNLFXWKKKXLJ-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(2-oxo-3-propylimidazolidin-1-yl)-1h-indazole-3-carboxamide Chemical compound O=C1N(CCC)CCN1C1=CC=C(C(=NN2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 GRUNLFXWKKKXLJ-GOSISDBHSA-N 0.000 claims 2
- JCBHEXJAZCRMNJ-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(3-methylpyrazol-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound N1=C(C)C=CN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 JCBHEXJAZCRMNJ-MRXNPFEDSA-N 0.000 claims 2
- AIEYPFNAZAQGDT-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(4-methyl-1,4-diazepan-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1CN(C)CCCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 AIEYPFNAZAQGDT-GOSISDBHSA-N 0.000 claims 2
- GPWNPAULGBLLEA-FAFZWHIHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(5-methyl-2,5-diazabicyclo[2.2.2]octan-2-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@@H]1NC(=O)C1=NSC2=CC(N3CC4CCC3CN4C)=CC=C21 GPWNPAULGBLLEA-FAFZWHIHSA-N 0.000 claims 2
- ZYXWSPGDIGRWLF-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(5-methylpyrazol-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound CC1=CC=NN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 ZYXWSPGDIGRWLF-MRXNPFEDSA-N 0.000 claims 2
- VNYHRDSBGYDAQL-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(cyclopropanecarbonylamino)-1-cyclopropylindazole-3-carboxamide Chemical compound C1CC1C(=O)NC(C=C12)=CC=C1C(C(=O)N[C@H]1C3CCN(CC3)C1)=NN2C1CC1 VNYHRDSBGYDAQL-GOSISDBHSA-N 0.000 claims 2
- QANNTZCRFNSNGO-NVXWUHKLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(3r)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@H](OC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 QANNTZCRFNSNGO-NVXWUHKLSA-N 0.000 claims 2
- VJGNOXVGSIIBKG-NVXWUHKLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(3r)-3-methoxypyrrolidin-1-yl]-1,2-benzoxazole-3-carboxamide Chemical compound C1[C@H](OC)CCN1C1=CC=C(C(=NO2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 VJGNOXVGSIIBKG-NVXWUHKLSA-N 0.000 claims 2
- CHHKUKIZVHLZHF-FUHWJXTLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](N(C)C)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 CHHKUKIZVHLZHF-FUHWJXTLSA-N 0.000 claims 2
- MQHHLXJJSOOTSK-GOEBONIOSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(3s)-3-hydroxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](O)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 MQHHLXJJSOOTSK-GOEBONIOSA-N 0.000 claims 2
- QANNTZCRFNSNGO-DOTOQJQBSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(3s)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](OC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 QANNTZCRFNSNGO-DOTOQJQBSA-N 0.000 claims 2
- SALPMAXLHRQAPQ-NFOQDIRWSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[1-(cyclopropanecarbonyl)-3,4,4a,5,7,7a-hexahydro-2h-pyrrolo[3,4-b]pyridin-6-yl]-1,2-benzothiazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N(CC12)CC1CCCN2C(=O)C1CC1 SALPMAXLHRQAPQ-NFOQDIRWSA-N 0.000 claims 2
- QKJMBWFYXTZCSM-BZSJEYESSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-(difluoromethoxy)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1C(OC(F)F)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 QKJMBWFYXTZCSM-BZSJEYESSA-N 0.000 claims 2
- JRLOWLLNQWPBTN-XPKAQORNSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-(methoxymethyl)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1C(COC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 JRLOWLLNQWPBTN-XPKAQORNSA-N 0.000 claims 2
- YWHWECOSJZZXMH-LJQANCHMSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[4-(cyclopropanecarbonyl)piperazin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N(CC1)CCN1C(=O)C1CC1 YWHWECOSJZZXMH-LJQANCHMSA-N 0.000 claims 2
- LSJTZJHCZCUIPE-BTQNPOSSSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-methoxy-1,2-benzoxazole-3-carboxamide;hydrochloride Chemical compound Cl.C1N(CC2)CCC2[C@@H]1NC(=O)C1=NOC2=CC(OC)=CC=C21 LSJTZJHCZCUIPE-BTQNPOSSSA-N 0.000 claims 2
- RAYAZVOIVKZYFJ-LLVKDONJSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-methoxy-[1,2]thiazolo[5,4-b]pyridine-3-carboxamide Chemical compound C1N(CC2)CCC2[C@@H]1NC(=O)C1=NSC2=NC(OC)=CC=C21 RAYAZVOIVKZYFJ-LLVKDONJSA-N 0.000 claims 2
- ACWVOGYINHFSIT-QGZVFWFLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-phenyl-2h-pyrazolo[3,4-b]pyridine-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NNC1=NC=2C1=CC=CC=C1 ACWVOGYINHFSIT-QGZVFWFLSA-N 0.000 claims 2
- OZIYFRRXGPXXDW-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-piperazin-1-yl-1,2-benzothiazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N1CCNCC1 OZIYFRRXGPXXDW-MRXNPFEDSA-N 0.000 claims 2
- NEHATUZWLDEXIQ-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-pyrrolidin-1-yl-1,2-benzothiazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N1CCCC1 NEHATUZWLDEXIQ-MRXNPFEDSA-N 0.000 claims 2
- GLTJKJAUUMPZNP-UKRRQHHQSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-7-[(3r)-3-hydroxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@H](O)CCN1C1=CC=CC2=C1SN=C2C(=O)N[C@H]1C(CC2)CCN2C1 GLTJKJAUUMPZNP-UKRRQHHQSA-N 0.000 claims 2
- OPNCHKXTZMMPLE-GDBMZVCRSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-7-[(3r)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@H](OC)CCN1C1=CC=CC2=C1SN=C2C(=O)N[C@H]1C(CC2)CCN2C1 OPNCHKXTZMMPLE-GDBMZVCRSA-N 0.000 claims 2
- XDPQUPREVRZXNO-LLVKDONJSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-7-fluoro-6-methoxy-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@@H]1NC(=O)C1=NSC2=C(F)C(OC)=CC=C21 XDPQUPREVRZXNO-LLVKDONJSA-N 0.000 claims 2
- BDDIUTHMWNWMRJ-UHFFFAOYSA-N octane;hydrobromide Chemical compound Br.CCCCCCCC BDDIUTHMWNWMRJ-UHFFFAOYSA-N 0.000 claims 2
- SRHHXHOIKKDDOY-UHFFFAOYSA-N octane;hydroiodide Chemical compound I.CCCCCCCC SRHHXHOIKKDDOY-UHFFFAOYSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- UXAWXZDXVOYLII-UHFFFAOYSA-N tert-butyl 2,5-diazabicyclo[2.2.1]heptane-2-carboxylate Chemical compound C1C2N(C(=O)OC(C)(C)C)CC1NC2 UXAWXZDXVOYLII-UHFFFAOYSA-N 0.000 claims 2
- 125000005960 1,4-diazepanyl group Chemical group 0.000 claims 1
- PPNCOQHHSGMKGI-UHFFFAOYSA-N 1-cyclononyldiazonane Chemical group C1CCCCCCCC1N1NCCCCCCC1 PPNCOQHHSGMKGI-UHFFFAOYSA-N 0.000 claims 1
- NFDXQGNDWIPXQL-UHFFFAOYSA-N 1-cyclooctyldiazocane Chemical group C1CCCCCCC1N1NCCCCCC1 NFDXQGNDWIPXQL-UHFFFAOYSA-N 0.000 claims 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- LXABWBMNYBJOLI-UHFFFAOYSA-N 1H-indazole-3-carbonyl isocyanate Chemical compound C(=O)=NC(=O)C1=NNC2=CC=CC=C12 LXABWBMNYBJOLI-UHFFFAOYSA-N 0.000 claims 1
- AKWIAIDKXNKXDI-UHFFFAOYSA-N 1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=CNC=1 AKWIAIDKXNKXDI-UHFFFAOYSA-N 0.000 claims 1
- DNAZCSLXJXKFSN-VJIKYCBLSA-N 5-hydroxy-n-[(3s)-1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl]-1,2-benzothiazole-3-carboxamide;iodide Chemical compound [I-].C1=C(O)C=C2C(C(=O)N[C@H]3C4CC[N+](CC4)(C3)C)=NSC2=C1 DNAZCSLXJXKFSN-VJIKYCBLSA-N 0.000 claims 1
- OEJKUAYPQOVDOO-WHCXFUJUSA-N 6-(3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl)-n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1CN2CCCC2CN1C1=CC=C2C(C(N[C@H]3C4CCN(CC4)C3)=O)=NSC2=C1 OEJKUAYPQOVDOO-WHCXFUJUSA-N 0.000 claims 1
- 102000009346 Adenosine receptors Human genes 0.000 claims 1
- 108050000203 Adenosine receptors Proteins 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- 229940127291 Calcium channel antagonist Drugs 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 claims 1
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 239000000480 calcium channel blocker Substances 0.000 claims 1
- 229930003827 cannabinoid Natural products 0.000 claims 1
- 239000003557 cannabinoid Substances 0.000 claims 1
- 239000000544 cholinesterase inhibitor Substances 0.000 claims 1
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical group C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 claims 1
- 229960003638 dopamine Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 230000003551 muscarinic effect Effects 0.000 claims 1
- PPNSPIJCCHPEIW-WBVHZDCISA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-5-[(3r)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@H](OC)CCN1C1=CC=C(SN=C2C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 PPNSPIJCCHPEIW-WBVHZDCISA-N 0.000 claims 1
- PPNSPIJCCHPEIW-RDJZCZTQSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-5-[(3s)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](OC)CCN1C1=CC=C(SN=C2C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 PPNSPIJCCHPEIW-RDJZCZTQSA-N 0.000 claims 1
- UFVCXVYNCMTGHK-INIZCTEOSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(1-methyl-4,5-dihydroimidazol-2-yl)-1h-indazole-3-carboxamide Chemical compound CN1CCN=C1C1=CC=C(C(=NN2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 UFVCXVYNCMTGHK-INIZCTEOSA-N 0.000 claims 1
- SERHSHYNJAZWGI-RUINGEJQSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(2-methylpiperazin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound CC1CNCCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 SERHSHYNJAZWGI-RUINGEJQSA-N 0.000 claims 1
- XNSPJZRHCSNVAR-KRWDZBQOSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(2-oxo-3-propylimidazolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound O=C1N(CCC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 XNSPJZRHCSNVAR-KRWDZBQOSA-N 0.000 claims 1
- QANNTZCRFNSNGO-LWKPJOBUSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(3-methoxypyrrolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1C(OC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 QANNTZCRFNSNGO-LWKPJOBUSA-N 0.000 claims 1
- ILUNTYBAPOBZGE-HNNXBMFYSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(4,5-dihydro-1h-imidazol-2-yl)-1h-indazole-3-carboxamide Chemical compound N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NNC1=CC=2C1=NCCN1 ILUNTYBAPOBZGE-HNNXBMFYSA-N 0.000 claims 1
- AIEYPFNAZAQGDT-SFHVURJKSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(4-methyl-1,4-diazepan-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1CN(C)CCCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 AIEYPFNAZAQGDT-SFHVURJKSA-N 0.000 claims 1
- IYXVKOKQRMOGQC-KRWDZBQOSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(4-methylpiperazin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 IYXVKOKQRMOGQC-KRWDZBQOSA-N 0.000 claims 1
- IVYWDRAWLTUMFE-TVPLGVNVSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-(8-methyl-3,8-diazabicyclo[3.2.1]octan-3-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@H]1NC(=O)C1=NSC2=CC(N3CC4CCC(C3)N4C)=CC=C21 IVYWDRAWLTUMFE-TVPLGVNVSA-N 0.000 claims 1
- FJXJLRUWWLSMTO-ZJOUEHCJSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(1s,4s)-5-(cyclopropylmethyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C([C@]1(N(C=2C=C3SN=C(C3=CC=2)C(=O)N[C@@H]2C3CCN(CC3)C2)C[C@@]2(C1)[H])[H])N2CC1CC1 FJXJLRUWWLSMTO-ZJOUEHCJSA-N 0.000 claims 1
- SALPMAXLHRQAPQ-QUENFVSXSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[1-(cyclopropanecarbonyl)-3,4,4a,5,7,7a-hexahydro-2h-pyrrolo[3,4-b]pyridin-6-yl]-1,2-benzothiazole-3-carboxamide Chemical compound N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N(CC12)CC1CCCN2C(=O)C1CC1 SALPMAXLHRQAPQ-QUENFVSXSA-N 0.000 claims 1
- OTUHCJJOIWVIEF-CVMIBEPCSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-1h-indazole-3-carboxamide Chemical compound C1C(N(C)C)CCN1C1=CC=C(C(=NN2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 OTUHCJJOIWVIEF-CVMIBEPCSA-N 0.000 claims 1
- KRVDZCIJALCFCD-DAFXYXGESA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-[methyl(2,2,2-trifluoroethyl)amino]pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1C(N(CC(F)(F)F)C)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 KRVDZCIJALCFCD-DAFXYXGESA-N 0.000 claims 1
- GOZVSIAXGOLHQP-IBGZPJMESA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-[4-(dimethylamino)piperidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1CC(N(C)C)CCN1C1=CC=C(C(=NS2)C(=O)N[C@@H]3C4CCN(CC4)C3)C2=C1 GOZVSIAXGOLHQP-IBGZPJMESA-N 0.000 claims 1
- XIYQUORHPQHVQN-AWEZNQCLSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-cyano-1h-indazole-3-carboxamide Chemical compound N#CC1=CC=C2C(C(N[C@@H]3C4CCN(CC4)C3)=O)=NNC2=C1 XIYQUORHPQHVQN-AWEZNQCLSA-N 0.000 claims 1
- HSNPCRQDMDXYQW-ZOWNYOTGSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-methoxy-1,2-benzothiazole-3-carboxamide;hydrochloride Chemical compound Cl.C1N(CC2)CCC2[C@H]1NC(=O)C1=NSC2=CC(OC)=CC=C21 HSNPCRQDMDXYQW-ZOWNYOTGSA-N 0.000 claims 1
- OZIYFRRXGPXXDW-INIZCTEOSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-6-piperazin-1-yl-1,2-benzothiazole-3-carboxamide Chemical compound N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N1CCNCC1 OZIYFRRXGPXXDW-INIZCTEOSA-N 0.000 claims 1
- OPNCHKXTZMMPLE-ZBFHGGJFSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-[(3r)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@H](OC)CCN1C1=CC=CC2=C1SN=C2C(=O)N[C@@H]1C(CC2)CCN2C1 OPNCHKXTZMMPLE-ZBFHGGJFSA-N 0.000 claims 1
- OPNCHKXTZMMPLE-HOCLYGCPSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-[(3s)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](OC)CCN1C1=CC=CC2=C1SN=C2C(=O)N[C@@H]1C(CC2)CCN2C1 OPNCHKXTZMMPLE-HOCLYGCPSA-N 0.000 claims 1
- XDPQUPREVRZXNO-NSHDSACASA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-fluoro-6-methoxy-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@H]1NC(=O)C1=NSC2=C(F)C(OC)=CC=C21 XDPQUPREVRZXNO-NSHDSACASA-N 0.000 claims 1
- YLWNWPRABKNCGA-CQSZACIVSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-(difluoromethyl)-6-(1,3-thiazol-2-yl)indazole-3-carboxamide Chemical compound C1=C2N(C(F)F)N=C(C(=O)N[C@H]3C4CCN(CC4)C3)C2=CC=C1C1=NC=CS1 YLWNWPRABKNCGA-CQSZACIVSA-N 0.000 claims 1
- OMIAFJAGVHVDCS-QGZVFWFLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-cyclopropyl-6-(1,3-thiazol-2-yl)indazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=C(C=C11)C=2SC=CN=2)=NN1C1CC1 OMIAFJAGVHVDCS-QGZVFWFLSA-N 0.000 claims 1
- DLARADLKNHHUJE-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-ethyl-6-(1,3-oxazol-2-yl)indazole-3-carboxamide Chemical compound C1=C2N(CC)N=C(C(=O)N[C@H]3C4CCN(CC4)C3)C2=CC=C1C1=NC=CO1 DLARADLKNHHUJE-MRXNPFEDSA-N 0.000 claims 1
- KRLDSELWMMWNML-PKLMIRHRSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-ethyl-6-(1,3-oxazol-2-yl)indazole-3-carboxamide;hydrochloride Chemical compound Cl.C1=C2N(CC)N=C(C(=O)N[C@H]3C4CCN(CC4)C3)C2=CC=C1C1=NC=CO1 KRLDSELWMMWNML-PKLMIRHRSA-N 0.000 claims 1
- IKXVBFQRYVFHDF-QGZVFWFLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1-propan-2-yl-6-(1,3-thiazol-2-yl)indazole-3-carboxamide Chemical compound C1=C2N(C(C)C)N=C(C(=O)N[C@H]3C4CCN(CC4)C3)C2=CC=C1C1=NC=CS1 IKXVBFQRYVFHDF-QGZVFWFLSA-N 0.000 claims 1
- HVKLEJMKAONLIB-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-5-(4-methyl-1,4-diazepan-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1CN(C)CCCN1C1=CC=C(SN=C2C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 HVKLEJMKAONLIB-GOSISDBHSA-N 0.000 claims 1
- HCHKVJNYNKHIGB-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(1,3-thiazol-2-yl)-1-thiophen-3-ylindazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=C(C=C11)C=2SC=CN=2)=NN1C=1C=CSC=1 HCHKVJNYNKHIGB-GOSISDBHSA-N 0.000 claims 1
- PBHKPYHGXWPPBB-QGZVFWFLSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(1,4-diazepan-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N1CCCNCC1 PBHKPYHGXWPPBB-QGZVFWFLSA-N 0.000 claims 1
- SERHSHYNJAZWGI-LRHAYUFXSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(2-methylpiperazin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound CC1CNCCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 SERHSHYNJAZWGI-LRHAYUFXSA-N 0.000 claims 1
- GJYQRQQHVVMNQQ-UNTBIKODSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(2-oxo-3-propylimidazolidin-1-yl)-1,2-benzothiazole-3-carboxamide;hydrochloride Chemical compound Cl.O=C1N(CCC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 GJYQRQQHVVMNQQ-UNTBIKODSA-N 0.000 claims 1
- WGFXFRVKAYTEOV-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(3-ethyl-2-oxoimidazolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound O=C1N(CC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 WGFXFRVKAYTEOV-MRXNPFEDSA-N 0.000 claims 1
- MQHHLXJJSOOTSK-BZSJEYESSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(3-hydroxypyrrolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1C(O)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 MQHHLXJJSOOTSK-BZSJEYESSA-N 0.000 claims 1
- QANNTZCRFNSNGO-OMOCHNIRSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(3-methoxypyrrolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1C(OC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 QANNTZCRFNSNGO-OMOCHNIRSA-N 0.000 claims 1
- BIBPBHIZDKQIOZ-PVQCJRHBSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(3-methyl-2-oxopyrrolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound O=C1C(C)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 BIBPBHIZDKQIOZ-PVQCJRHBSA-N 0.000 claims 1
- XXXHTSQDIORPMB-GOSISDBHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(4-methylpiperazine-1-carbonyl)-1h-indazole-3-carboxamide Chemical compound C1CN(C)CCN1C(=O)C1=CC=C(C(=NN2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 XXXHTSQDIORPMB-GOSISDBHSA-N 0.000 claims 1
- IVYWDRAWLTUMFE-FAFZWHIHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-(8-methyl-3,8-diazabicyclo[3.2.1]octan-3-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@@H]1NC(=O)C1=NSC2=CC(N3CC4CCC(C3)N4C)=CC=C21 IVYWDRAWLTUMFE-FAFZWHIHSA-N 0.000 claims 1
- YIPLPZONCABMSW-JLJPHGGASA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(1s,4s)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@@H]1NC(=O)C1=NSC2=CC(N3C[C@]4(NC[C@]3([H])C4)[H])=CC=C21 YIPLPZONCABMSW-JLJPHGGASA-N 0.000 claims 1
- YASULIPENFCLRY-CMKODMSKSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(1s,4s)-2-(cyclopropanecarbonyl)-2,5-diazabicyclo[2.2.1]heptan-5-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C([C@]1(N(C=2C=C3SN=C(C3=CC=2)C(=O)N[C@H]2C3CCN(CC3)C2)C[C@@]2(C1)[H])[H])N2C(=O)C1CC1 YASULIPENFCLRY-CMKODMSKSA-N 0.000 claims 1
- FJXJLRUWWLSMTO-IRFCIJBXSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(1s,4s)-5-(cyclopropylmethyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C([C@]1(N(C=2C=C3SN=C(C3=CC=2)C(=O)N[C@H]2C3CCN(CC3)C2)C[C@@]2(C1)[H])[H])N2CC1CC1 FJXJLRUWWLSMTO-IRFCIJBXSA-N 0.000 claims 1
- DOUKNGQHWNTBGW-CMKODMSKSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(1s,4s)-5-cyclopropyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C([C@]1(N(C=2C=C3SN=C(C3=CC=2)C(=O)N[C@H]2C3CCN(CC3)C2)C[C@@]2(C1)[H])[H])N2C1CC1 DOUKNGQHWNTBGW-CMKODMSKSA-N 0.000 claims 1
- DQWZCYLIBXHEIN-XYJFISCASA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1N(CC2)CCC2[C@@H]1NC(=O)C1=NSC2=CC(N3C[C@]4(N(C[C@]3([H])C4)C)[H])=CC=C21 DQWZCYLIBXHEIN-XYJFISCASA-N 0.000 claims 1
- VJGNOXVGSIIBKG-DOTOQJQBSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[(3s)-3-methoxypyrrolidin-1-yl]-1,2-benzoxazole-3-carboxamide Chemical compound C1[C@@H](OC)CCN1C1=CC=C(C(=NO2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 VJGNOXVGSIIBKG-DOTOQJQBSA-N 0.000 claims 1
- AFFLFHWMOOWDQB-ROPPNANJSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-(cyclopropylmethoxy)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N(C1)CCC1OCC1CC1 AFFLFHWMOOWDQB-ROPPNANJSA-N 0.000 claims 1
- OFFFQICGZLVGEA-FBMWCMRBSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-(methylamino)pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1C(NC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 OFFFQICGZLVGEA-FBMWCMRBSA-N 0.000 claims 1
- KRVDZCIJALCFCD-UHUGOGIASA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[3-[methyl(2,2,2-trifluoroethyl)amino]pyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1C(N(CC(F)(F)F)C)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 KRVDZCIJALCFCD-UHUGOGIASA-N 0.000 claims 1
- GOZVSIAXGOLHQP-LJQANCHMSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-[4-(dimethylamino)piperidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1CC(N(C)C)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1 GOZVSIAXGOLHQP-LJQANCHMSA-N 0.000 claims 1
- HSNPCRQDMDXYQW-BTQNPOSSSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-methoxy-1,2-benzothiazole-3-carboxamide;hydrochloride Chemical compound Cl.C1N(CC2)CCC2[C@@H]1NC(=O)C1=NSC2=CC(OC)=CC=C21 HSNPCRQDMDXYQW-BTQNPOSSSA-N 0.000 claims 1
- ZCZQEVPJJXRPAQ-MRXNPFEDSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-6-pyrrol-1-yl-1,2-benzothiazole-3-carboxamide Chemical compound N([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NSC1=CC=2N1C=CC=C1 ZCZQEVPJJXRPAQ-MRXNPFEDSA-N 0.000 claims 1
- OPNCHKXTZMMPLE-BZSJEYESSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-7-(3-methoxypyrrolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1C(OC)CCN1C1=CC=CC2=C1SN=C2C(=O)N[C@H]1C(CC2)CCN2C1 OPNCHKXTZMMPLE-BZSJEYESSA-N 0.000 claims 1
- GLTJKJAUUMPZNP-DZGCQCFKSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-7-[(3s)-3-hydroxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](O)CCN1C1=CC=CC2=C1SN=C2C(=O)N[C@H]1C(CC2)CCN2C1 GLTJKJAUUMPZNP-DZGCQCFKSA-N 0.000 claims 1
- OPNCHKXTZMMPLE-GOEBONIOSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-7-[(3s)-3-methoxypyrrolidin-1-yl]-1,2-benzothiazole-3-carboxamide Chemical compound C1[C@@H](OC)CCN1C1=CC=CC2=C1SN=C2C(=O)N[C@H]1C(CC2)CCN2C1 OPNCHKXTZMMPLE-GOEBONIOSA-N 0.000 claims 1
- SNBVUKVTZTVDTO-AWKYBWMHSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-7-fluoro-6-(3-methoxypyrrolidin-1-yl)-1,2-benzothiazole-3-carboxamide Chemical compound C1C(OC)CCN1C1=CC=C(C(=NS2)C(=O)N[C@H]3C4CCN(CC4)C3)C2=C1F SNBVUKVTZTVDTO-AWKYBWMHSA-N 0.000 claims 1
- GGWTWAGLQPRLGQ-UTONKHPSSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-7-methoxy-1,2-benzothiazole-3-carboxamide;hydrochloride Chemical compound Cl.C1N(CC2)CCC2[C@@H]1NC(=O)C1=NSC2=C1C=CC=C2OC GGWTWAGLQPRLGQ-UTONKHPSSA-N 0.000 claims 1
- WQLZMRXMTRRRQR-LJQANCHMSA-N n-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-n-methyl-6-(oxan-4-yl)-1h-indazole-3-carboxamide Chemical compound CN([C@H]1C2CCN(CC2)C1)C(=O)C(C1=CC=2)=NNC1=CC=2C1CCOCC1 WQLZMRXMTRRRQR-LJQANCHMSA-N 0.000 claims 1
- INYJGWAMAOSZQJ-UHFFFAOYSA-N oxamide;hydrochloride Chemical compound Cl.NC(=O)C(N)=O INYJGWAMAOSZQJ-UHFFFAOYSA-N 0.000 claims 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 229940076279 serotonin Drugs 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71955205P | 2005-09-23 | 2005-09-23 | |
| PCT/US2006/037142 WO2007038367A1 (en) | 2005-09-23 | 2006-09-22 | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009509964A JP2009509964A (ja) | 2009-03-12 |
| JP2009509964A5 true JP2009509964A5 (enExample) | 2010-01-07 |
Family
ID=37715973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008532459A Pending JP2009509964A (ja) | 2005-09-23 | 2006-09-22 | インダゾール類、ベンゾチアゾール類、ベンゾイソオキサゾール類、ピラゾロピリジン類、イソチアゾロピリジン類、およびそれらの製造と用途 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1940833A1 (enExample) |
| JP (1) | JP2009509964A (enExample) |
| KR (1) | KR20080048550A (enExample) |
| CN (1) | CN101312968A (enExample) |
| AU (1) | AU2006295397A1 (enExample) |
| BR (1) | BRPI0617534A2 (enExample) |
| CA (1) | CA2622677A1 (enExample) |
| IL (1) | IL190358A0 (enExample) |
| RU (1) | RU2450003C2 (enExample) |
| SG (1) | SG165417A1 (enExample) |
| WO (1) | WO2007038367A1 (enExample) |
| ZA (1) | ZA200802342B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| NZ570524A (en) | 2006-03-28 | 2011-08-26 | High Point Pharmaceuticals Llc | Benzothiazoles having histamine H3 receptor activity |
| SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| EP2231600B1 (en) * | 2007-11-16 | 2015-07-29 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| KR20100101171A (ko) * | 2008-02-15 | 2010-09-16 | 에프. 호프만-라 로슈 아게 | 3-알킬-피페라진 유도체 및 이의 용도 |
| WO2010043515A1 (en) * | 2008-10-13 | 2010-04-22 | F. Hoffmann-La Roche Ag | Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides |
| HUE026815T2 (en) | 2008-11-19 | 2016-07-28 | Forum Pharmaceuticals Inc | Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| TWI558398B (zh) | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α７活化劑之用途 |
| US20110172428A1 (en) | 2010-01-12 | 2011-07-14 | Shan-Ming Kuang | Methods for the preparation of indazole-3-carboxylic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt |
| CN103025744A (zh) * | 2010-04-30 | 2013-04-03 | 百时美施贵宝公司 | 作为α-7烟碱乙酰胆碱受体配体前药的氮杂二环胺N-氧化物化合物 |
| TWI519532B (zh) | 2010-05-17 | 2016-02-01 | 艾維沃製藥公司 | （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體 |
| US8242276B2 (en) | 2010-06-30 | 2012-08-14 | Hoffmann-La Roche Inc. | Methods for the preparation of N-(S)-1-azabicyclo[2.2.2]oct-3-yl-1H-indazole-3-carboxamide hydrochloride salt |
| CA2808797A1 (en) | 2010-07-26 | 2012-02-02 | Envivo Pharmaceuticals, Inc. | Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptor agonists in combination with acetylcholinesterase inhibitors |
| AR086791A1 (es) * | 2011-07-01 | 2014-01-22 | Lundbeck & Co As H | Moduladores alostericos positivos del receptor de acetilcolina nicotinico |
| RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
| JOP20130213B1 (ar) | 2012-07-17 | 2021-08-17 | Takeda Pharmaceuticals Co | معارضات لمستقبلht3-5 |
| MA37975B2 (fr) * | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
| WO2014061676A1 (ja) * | 2012-10-16 | 2014-04-24 | 武田薬品工業株式会社 | 複素環化合物 |
| BR112015031155A2 (pt) | 2013-06-20 | 2017-07-25 | Bayer Cropscience Ag | derivados de sulfureto de arila e derivados de aril sulfóxido como acaricidas e inseticidas |
| EP3030555B1 (en) * | 2013-08-08 | 2019-01-30 | Boehringer Ingelheim International GmbH | Novel pyrazine amide compounds |
| BR112016021626A2 (pt) | 2014-03-20 | 2018-05-15 | Samumed, Llc | indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas |
| KR101532211B1 (ko) * | 2014-04-30 | 2015-06-30 | 세종대학교산학협력단 | Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물 및 방법 |
| JP7055017B2 (ja) | 2014-09-29 | 2022-04-15 | 武田薬品工業株式会社 | 結晶形の１－（１－メチル－１ｈ－ピラゾール－４－イル）－ｎ－（（１ｒ，５ｓ，７ｓ）－９－メチル－３－オキサ－９－アザビシクロ［３．３．１］ノナン－７－イル）－１ｈ－インドール－３－カルボキサミド |
| CN107847494A (zh) * | 2015-06-10 | 2018-03-27 | 阿考温特科学股份有限公司 | 作为α7‑烟碱乙酰胆碱受体激动剂的氨基苯并异噁唑化合物 |
| US10428062B2 (en) | 2015-08-12 | 2019-10-01 | Axovant Sciences Gmbh | Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors |
| CN116270646A (zh) * | 2015-10-16 | 2023-06-23 | 艾伯维公司 | 制备咪唑并[1,2-a]吡咯并[2,3-e]吡嗪类化合物及其固态形式的方法 |
| AU2018249675B2 (en) | 2017-04-06 | 2021-08-19 | Inventiva | New compounds inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesothelioma. |
| EP3632908A1 (en) | 2018-10-02 | 2020-04-08 | Inventiva | Inhibitors of the yap/taz-tead interaction and their use in the treatment of cancer |
| PT3920912T (pt) | 2019-02-04 | 2025-09-09 | Genzyme Corp | Tratamento de ciliopatias usando inibidores da glucosilceramida sintase (gcs) |
| IL295255A (en) | 2020-02-03 | 2022-10-01 | Genzyme Corp | Methods for treating neurological symptoms associated with lysosomal storage diseases |
| US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| IL300090A (en) | 2020-07-24 | 2023-03-01 | Genzyme Corp | Pharmaceutical preparations containing VENGLUSTAT |
| US11319319B1 (en) | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| US12331048B2 (en) | 2022-10-31 | 2025-06-17 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2067979C1 (ru) * | 1992-02-04 | 1996-10-20 | Эйсай Ко. Лтд. | Производное аминобензойной кислоты или его фармацевтически приемлемая соль |
| AR036040A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| AR036041A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
| DE10162375A1 (de) * | 2001-12-19 | 2003-07-10 | Bayer Ag | Bicyclische N-Aryl-amide |
| MXPA05001702A (es) * | 2002-08-14 | 2005-04-19 | Neurosearch As | Derivados de quinuclidina novedosos y su uso. |
| CA2499128C (en) * | 2002-09-25 | 2012-07-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| MXPA05007689A (es) * | 2003-01-22 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Tratamiento de enfermedades con agonistas completos del receptor alfa-7 de nach. |
| PL1697378T3 (pl) * | 2003-12-22 | 2008-04-30 | Memory Pharm Corp | Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania |
-
2006
- 2006-09-22 CN CNA2006800439794A patent/CN101312968A/zh active Pending
- 2006-09-22 WO PCT/US2006/037142 patent/WO2007038367A1/en not_active Ceased
- 2006-09-22 KR KR1020087009574A patent/KR20080048550A/ko not_active Ceased
- 2006-09-22 BR BRPI0617534-1A patent/BRPI0617534A2/pt not_active IP Right Cessation
- 2006-09-22 JP JP2008532459A patent/JP2009509964A/ja active Pending
- 2006-09-22 RU RU2008115268/04A patent/RU2450003C2/ru not_active IP Right Cessation
- 2006-09-22 EP EP06815264A patent/EP1940833A1/en not_active Withdrawn
- 2006-09-22 AU AU2006295397A patent/AU2006295397A1/en not_active Abandoned
- 2006-09-22 CA CA002622677A patent/CA2622677A1/en not_active Abandoned
- 2006-09-22 SG SG201006955-7A patent/SG165417A1/en unknown
-
2008
- 2008-03-12 ZA ZA200802342A patent/ZA200802342B/xx unknown
- 2008-03-20 IL IL190358A patent/IL190358A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2450003C2 (ru) | Индазолы, бензотиазолы, бензоизотиазолы, бензоизоксазолы, пиразолопиридины, изотиазолопиридины, их получение и их применение | |
| US10934302B1 (en) | SHP2 phosphatase inhibitors and methods of use thereof | |
| CN119677749A (zh) | 氮杂喹唑啉泛KRas抑制剂 | |
| JP2020522570A5 (enExample) | ||
| JP2014506929A5 (enExample) | ||
| JP2021503004A5 (enExample) | ||
| JP2014528482A5 (enExample) | ||
| RU2020129785A (ru) | Фармацевтические производные 6,5-гетеробициклического кольца | |
| JP2015504057A5 (enExample) | ||
| JP2011500774A5 (enExample) | ||
| JP2017524734A5 (enExample) | ||
| KR20110039307A (ko) | 이미다조피리딘-2-온 유도체 | |
| RU2014119244A (ru) | Гетероциклические соединения и способы их использования | |
| US12319671B2 (en) | 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof | |
| RU2014123316A (ru) | Ингибиторы фосфодиэстеразы типа 10а | |
| JP2015512888A5 (enExample) | ||
| AR091315A1 (es) | Inhibidores de benzodioxano de la produccion de leucotrieno | |
| HRP20160649T1 (hr) | Novi derivati tienopirimidina, postupci za njihovo pripremanje i njihova terapeutska uporaba | |
| JP2016500694A5 (enExample) | ||
| JP2011506466A5 (enExample) | ||
| JP2020526549A5 (enExample) | ||
| JP7478676B2 (ja) | Ｇａｂａ ａ ａｌｐｈａ５ ｐａｍとしての新規イソオキサゾリルエーテル誘導体 | |
| SG177523A1 (en) | 5-ht3 receptor modulators, methods of making, and use thereof | |
| JP2021525220A5 (enExample) | ||
| KR20230107291A (ko) | PPARγ 조절제 및 사용 방법 |